梯瓦制药（Teva Pharmaceutical）在美国上市的股票在盘前交易中上涨了3.5%。此前，该公司宣布其治疗免疫系统疾病的药物在中期临床试验中达到了主要目标。这一消息提振了投资者信心，推动股价在盘前时段走高。
梯瓦制药（Teva Pharmaceutical）在美国上市的股票在盘前交易中上涨了3.5%。此前，该公司宣布其治疗免疫系统疾病的药物在中期临床试验中达到了主要目标。这一消息提振了投资者信心，推动股价在盘前时段走高。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.